Asthma control or severity: that is the question

被引:74
作者
Humbert, M. [1 ]
Holgate, S.
Boulet, L. -P.
Bousquet, J.
机构
[1] Univ Paris 11, Hop Antoine Beclere, INSERM, Serv Pneumol,U764, Clamart, France
[2] Southampton Gen Hosp, Sch Med, Southampton SO9 4XY, Hants, England
[3] Univ Laval, Hop Laval, Inst Univ Cardiol & Pneumol, Unite Rech Pneumol,Ctr Rech, Quebec City, PQ G1K 7P4, Canada
[4] Univ Hosp, Hop Arnaud Villeneuve, Serv Malad Resp, Montpellier, France
基金
英国医学研究理事会;
关键词
asthma; guidelines;
D O I
10.1111/j.1398-9995.2006.01308.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
In the first National Heart Lung and Blood Institute and Global Initiative for Asthma (GINA) guidelines, the level of symptoms and airflow limitation and its variability allowed asthma to be subdivided by severity into four subcategories (intermittent, mild persistent, moderate persistent, and severe persistent). It is important to recognize, however, that asthma severity involves both the severity of the underlying disease and its responsiveness to treatment. Thus, the first update of the GINA guidelines defined asthma severity depending on the clinical features already proposed as well as the current treatment of the patient. In addition, severity is not a fixed feature of asthma, but may change over months or years, whereas the classification by severity suggests a static feature. Moreover, using severity as an outcome measure has limited value in predicting what treatment will be required and what the response to that treatment might be. Because of these considerations, the classi. cation of asthma severity is no longer recommended as the basis for treatment decisions, a periodic assessment of asthma control being more relevant and useful.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 86 条
[1]  
[Anonymous], 1990, BRIT MED J, V301, P651
[2]   COMMUNITY OUTBREAKS OF ASTHMA ASSOCIATED WITH INHALATION OF SOYBEAN DUST [J].
ANTO, JM ;
SUNYER, J ;
RODRIGUEZROISIN, R ;
SUAREZCERVERA, M ;
VAZQUEZ, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (17) :1097-1102
[3]   Classifying asthma severity in children - Mismatch between symptoms, medication use, and lung function [J].
Bacharier, LB ;
Strunk, RC ;
Mauger, D ;
White, D ;
Lemanske, RF ;
Sorkness, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (04) :426-432
[4]   Severity and control of severe asthma [J].
Bateman, ED .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (03) :519-521
[5]   Can guideline-defined asthma control be achieved? The gaining optimal asthma control study [J].
Bateman, ED ;
Boushey, HA ;
Bousquet, J ;
Busse, WW ;
Clark, TJH ;
Pauwels, RA ;
Pedersen, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :836-844
[6]   Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone [J].
Baumgartner, RA ;
Martinez, G ;
Edelman, JM ;
Gomez, GGR ;
Bernstein, M ;
Bird, S ;
Angner, R ;
Polis, A ;
Dass, SB ;
Lu, S ;
Reiss, TF .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (01) :123-128
[7]   Human late asthmatic reactions [J].
Bentley, AM ;
Kay, AB ;
Durham, SR .
CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 :71-86
[8]  
Berry MA, 2006, NEW ENGL J MED, V354, P2075
[9]   Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial [J].
Bjermer, L ;
Bisgaard, H ;
Bousquet, J ;
Fabbri, LM ;
Greening, AP ;
Haahtela, T ;
Holgate, ST ;
Picado, C ;
Menten, J ;
Dass, SB ;
Leff, JA ;
Polos, PG .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7420) :891-895
[10]   Smoking and asthma -: Clinical and radiologic features, lung function, and airway inflammation [J].
Boulet, LP ;
Lemière, C ;
Archambault, F ;
Carrier, G ;
Descary, MC ;
Deschesnes, F .
CHEST, 2006, 129 (03) :661-668